EM2301E "Teaching the Old Dog New Tricks: Efforts to Reform Clinical Trial Design and Conduct" (IM GR-012723)

Purpose and Overview

Clinical trials offer patients access to promising therapies, answer important clinical questions, and lead to new and better treatments. However, stringent eligibility criteria, complex study procedures, and other factors limit trial enrollment, thereby increasing costs, decreasing generalizability of results, and delaying medical advances. Recent efforts from investigators, advocacy organizations, and regulatory authorities have addressed many of these inefficiencies.

Target Audience

physicians, nurse clinicians, physician assistants and nurses.

 

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Appreciate the development and impact of clinical trial eligibility criteria.
  • Understand factors that may limit the activation of clinical trials at sites providing care to diverse populations. 
  • Identify changes to clinical trial practice allowed by U.S. regulatory authorities during the COVID-19 public health emergency.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
01/30/2023
Course expires: 
02/28/2023
Cost:
$0.00
Rating: 
0

Photo: First Last, M.D.David Gerber, M.D.
Professor of Internal Medicine
Co-Director of Experimental Therapeutics Program
Division of Hematology/Oncology

 

Available Credit

  • 1.00 AMA

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome